T Helper 17 cells and regulatory t-cell imbalance in paediatric patients with asthma

Journal of International Medical Research

Volumn 39, Issue 4, 2011, Pages 1293-1305

  Wei, B ^a   Zhang, H ^a   Li, L ^a   Li, M ^a   Shang, Y ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Asthma; Immunity; Paediatric patients; Regulatory t cells; T helper 17 cells

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ARTICLE; ASTHMA; CASE REPORT; CD4+ T LYMPHOCYTE; CHILD; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG FUNCTION TEST; LUNG LAVAGE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE; LYMPHOCYTE SUBPOPULATION; MALE; PATHOGENESIS; PEDIATRICS; PRESCHOOL CHILD; REGULATORY T LYMPHOCYTE; RNA ANALYSIS; SCHOOL CHILD; TH17 CELL;

EID: 80052220905     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001103900417     Document Type: Article

References (58)

1. Wills-Karp M: Immunologic basis of antigeninduced airway hyperresponsiveness. Annu Rev Immunol 1999; 17: 255-281.
2. Kim HY, DeKruyff RH, Umetsu DT: The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat Immunol 2010; 11: 577-584.
3. Larché M, Robinson DS, Kay AB: The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 2003; 111: 450-463.
4. Baraldo S, Lokar Oliani K, Turato G, et al: The role of lymphocytes in the pathogenesis of asthma and COPD. Curr Med Chem 2007; 14: 2250-2256.
5. Peck A, Mellins ED: Plasticity of T-cell phenotype and function: the T helper type 17 example. Immunology 2010; 129: 147-153.
6. Awasthi A, Kuchroo VK: Th17 cells: from precursors to players in inflammation and infection. Int Immunol 2009; 21: 489-498.
7. Molet S, Hamid Q, Davoine F, et al: IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001; 108: 430-438.
8. Barczyk A, Pierzchala W, Sozañska E: Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med 2003; 97: 726-733.
9. Park H, Li Z, Yang XO, et al: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-1141.
10. Umetsu DT, DeKruyff RH: Immunedysregulation in asthma. Curr Opin Immunol 2006; 18: 727-732.
11. Robinson DS: The role of regulatory T lymphocytes in asthma pathogenesis. Curr Allergy Asthma Rep 2005; 5: 136-141.
12. Sakaguchi S, Wing K, Onishi Y, et al: Regulatory T cells: how do they suppress immune responses? Int Immunol 2009; 21: 1105-1111.
13. Hartl D, Koller B, Mehlhorn AT, et al: Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol 2007; 119: 1258-1266.
14. Grindebacke H, Wing K, Andersson AC, et al: Defective suppression of Th2 cytokines by CD4+CD25+ regulatory T cells in birch allergics during birch pollen season. Clin Exp Allergy 2004: 34: 1364-1372.
15. Ling EM, Smith T, Nguyen XD, et al: Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004; 363: 608-615.
16. Kearley J, Barker JE, Robinson DS, et al: Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med 2005; 202: 1539-1547.
17. Strickland DH, Stumbles PA, Zosky GR, et al: Reversal of airway hyperresponsiveness by induction of airway mucosal CD4+CD25+ regulatory T cells. J Exp Med 2006; 203: 2649-2660.
18. Akbari O, Freeman GJ, Meyer EH, et al: Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002; 8: 1024-1032.
19. Lewkowich IP, Herman NS, Schleifer KW, et al: CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J Exp Med 2005; 202: 1549-1561.
20. Sakaguchi S, Ono M, Setoguchi R, et al: Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006; 212: 8-27.
21. Bettelli E, Oukka M, Kuchroo VK: TH-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007; 8: 345-350.
22. American Thoracic Society: Guidelines for assessing and managing asthma risk at work, school, and recreation. Am J Respir Crit Care Med 2004; 169: 873-881.
23. Murphy DM, O'Byrne PM: Recent advances in the pathophysiology of asthma. Chest 2010; 137: 1417-1426.
24. Veldhoen M, Stockinger B: TGFβ1, a "Jack of all trades": the link with pro-inflammatory IL-17- producing T cells. Trends Immunol 2006; 27: 358-361.
25. Kukreja A, Cost G, Marker J, et al: Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 2002; 109: 131-140.
26. Ehrenstein MR, Evans JG, Singh A, et al: Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF therapy. J Exp Med 2004; 200: 277-285.
27. Viglietta V, Baecher-Allan C, Weiner HL, et al: Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199: 971-979.
28. Morgan ME, Flierman R, van Duivenvoorde LM, et al: Effective treatment of collageninduced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum 2005; 52: 2212-2221.
29. Denning TL, Kim G, Kronenberg M: Cutting edge: CD4+CD25+ regulatory T cells impaired for intestinal homing can prevent colitis. J Immunol 2005; 174: 7487-7491.
30. Tang Q, Henriksen KJ, Bi M, et al: In vitroexpanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004; 199: 1455-1465.
31. Mekala DJ, Geiger TL: Immunotherapy of autoimmune encephalomyelitis with redirected CD4+CD25+ T lymphocytes. Blood 2005; 105: 2090-2092.
32. Lee JH, Yu HH, Wang LC, et al: The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma. Clin Exp Immunol 2007; 148: 53-63.
33. Ryanna K, Stratigou V, Safinia N, et al: Regulatory T cells in bronchial asthma. Allergy 2009; 64: 335-347.
34. Nguyen KD, Vanichsarn C, Fohner A, et al: Selective deregulation in chemokine signaling pathways of CD4+CD25hiCD127lo/- regulatory T cells in human allergic asthma. J Allergy Clin Immunol 2009; 123: 933.e10-939.e10.
35. Wang LH, Lin YH, Yang J, et al: Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma. Int Arch Allergy Immunol 2009; 148: 199-210.
36. Finotto S, Eigenbrod T, Karwot R, et al: Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells. Int Immunol 2007; 19: 685-693.
37. Tournoy KG, Hove C, Grooten J, et al: Animal models of allergen-induced tolerance in asthma: are T-regulatory-1 cells (Tr-1) the solution for T-helper-2 cells (Th-2) in asthma? Clin Exp Allergy 2006; 36: 8-20.
38. Lin YL, Shieh CC, Wang JY: The functional insufficiency of human CD4+CD25high Tregulatory cells in allergic asthma is subjected to TNF-α modulation. Allergy 2008; 63: 67-74.
39. Chen W, Jin W, Hardegen N, et al: Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875-1886.
40. Mucida D, Park Y, Kim G, et al: Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007; 317: 256-260.
41. Liebhart J, Cembrzyn ́ska-Nowak M, Bien ́kowska M, et al: Relevance of the selected cytokine release (TNF-alpha, IL-6, IFN-gamma, and IFNalpha) to the exacerbation of bronchial asthma from airway mycotic infections. Predominant role of TFN-alpha? J Investig Allergol Clin Immunol 2002; 12: 182-191.
42. Cembrzy ́nska-Nowak M, Liebhart J, Banaszek B, et al: TNF-alpha, IL-6 and IFN-gamma secreted by bronchoalveolar leukocytes isolated from patients with bronchial asthma, complicated by fungal airways infections. Arch Immunol Ther Exp (Warsz) 1998; 46: 381-386.
43. Veldhoen M, Hocking RJ, Atkins CJ, et al: TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17- producing T cells. Immunity 2006; 24: 179-189.
44. Bettelli E, Carrier Y, Gao W, et al: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-238.
45. Mangan PR, Harrington LE, O'Quinn DB, et al: Transforming growth factor-β induces development of the TH17 lineage. Nature 2006; 441: 231-234.
46. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, et al: Interleukins 1beta and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007; 8: 942-949.
47. Wilson NJ, Boniface K, Chan JR, et al: Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007; 8: 950-957.
48. Ivanov II, McKenzie BS, Zhou L, et al: The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL- 17+ T helper cells. Cell 2006; 126: 1121-1133.
49. Kolls JK, Linden A: Interleukin-17 family members and inflammation. Immunity 2004; 21: 467-476.
50. Bullens DM, Truyen E, Coteur L, et al: IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res 2006; 7: 135.
51. Wong CK, Ho CY, Ko FW, et al: Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-γ, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol 2001; 125: 177-183.
52. Kim YS, Hong SW, Choi JP, et al: Vascular endothelial growth factor is a key mediator in the development of T cell priming and its polarization to type 1 and type 17 T helper cells in the airways. J Immunol 2009; 183: 5113-5120.
53. Saeki K, Fukuyama S, Ayada T, et al: A major lipid raft protein raftlin modulates T cell receptor signaling and enhances Th17- mediated autoimmune responses. J Immunol 2009; 182: 5929-5937.
54. Lewkowich IP, Lajoie S, Clark JR, et al: Allergen uptake, activation, and IL-23 production by pulmonary myeloid DCs drives airway hyperresponsiveness in asthma-susceptible mice. PLoS One 2008; 3: e3879.
55. Chakir J, Shannon J, Molet S, et al: Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-β, IL- 11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol 2003; 111: 1293-1298.
56. Song C, Luo L, Lei Z, et al: IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J Immunol 2008; 181: 6117-6124.
57. Chen Z, Tato CM, Muul L, et al: Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum 2007; 56: 2936-2946.
58. Linden A: Rationale for targeting interleukin- 17 in the lungs. Curr Opin Investig Drugs 2003; 4: 1304-1312.